Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
Tóm tắt
Từ khóa
Tài liệu tham khảo
Minami, M. et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad .Sci. USA 93, 3963–3966 (1996).
Peters, M. et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183, 1399–1406 (1996).
Peters, M. et al. Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice. J. Exp. Med. 185 , 755–766 (1997).
Peters, M., Müller, A. & Rose-John, S. Interleukin-6 and soluble interleukin-6 receptor: Direct stimulation of gp130 and hematopoiesis. Blood 92, 3295–3504 (1998).
Romano, M. et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 5, 315 –325 (1997).
Rose-John, S. & Heinrich, P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281–290 ( 1994).
Tamura, T. et al. Soluble IL-6 receptor triggers osteoclast formation by IL-6. Proc. Natl. Acad. Sci. USA 90, 11924– 11928 (1993).
Strober, W. & Neurath, M.F in Clinical Immunology (R.R. Rich, editor) 1401–1428 (Mosby, St. Louis, 1995).
Sartor, R. Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream. Gastroenterology 114, 398– 400 (1998).
Boirivant, M. et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 116, 557–565 ( 1999).
Ina, K. et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a bcl-2/bax mucosal imbalance. J. Immunol. 163, 1081–1090 (1999).
Gross, V., Andus, T, Caesar, I., Roth, M. & Schölmerich, J. Evidence for continuous stimulation of IL-6 production in Crohn's disease. Gastroenterology 102, 514–519 (1992).
Reinecker, H. C. et al. Enhanced secretion of tumour necrosis factor-α, IL6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94, 174–181 ( 1993).
Catlett-Falcone, R. et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105–115 (1999).
Fukada, T. et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5, 449–460 ( 1996).
Teague, T.K., Marrack, P., Kappler, J.W. & Vella, A.T. IL-6 rescues resting mouse T cells from apoptosis. J. Immunol. 158, 5791–5796 ( 1997).
Powrie, F. et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 2, 553–562 ( 1994).
Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E. & Strober, W. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1280– 1289 (1995).
Kühn, R., Löhler, J. Rennick, D. Rajewsky, K. & Müller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274 (1993).
Targan, S.R. et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. New Engl. J. Med. 337, 1029–1035 ( 1997).
Mullberg, J. et al. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155, 5198–5205 (1995).
Mitsuyama, K. et al. Soluble IL-6 receptors in inflammatory bowel disease: relation to circulating IL-6. Gut 36, 45– 49 (1995).
Bouhnik, Y. et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurin. Lancet 347, 215–219 (1996).
Jones, S.A. et al. C-reactive Protein: A physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189, 599 –604 (1999).